Airway Clearance Devices
Customize your policy alerts
Sign up for Capital Bluecross Policy MP 6.015 alerts
Get alerted when Policy MP 6.015 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and coverage criteria for airway clearance devices (oscillatory PEP devices, high-frequency chest compression systems, mechanical percussors) for outpatient use and who may qualify.
No material clinical or coverage changes in this revision.
Coverage Criteria for Airway Clearance Devices
Mechanical percussors
Considered medically necessary when ALL of the following are met:
High-frequency chest compression systems / IPV - initial coverage
Considered medically necessary when ALL of the following are met:
High-frequency chest compression systems - continuation of coverage
Continued coverage after a 30-day trial is considered medically necessary when BOTH of the following are met:
Oscillating PEP devices
Considered medically necessary when ALL of the following are met:
Covered Indications (codes listed)
Covered when medically necessary (codes listed)
This policy applies to outpatient use of airway clearance devices only. Inpatient device use, including use in the immediate postoperative period, is not included within this policy and is excluded from these coverage criteria. Trial selection and device type should reflect outpatient clinical needs and the fact that responses to different devices vary among individuals.
Coverage determinations in this policy are subject to the member's benefit program and eligibility on the date of service. These medical policy statements do not guarantee coverage or payment; final adjudication is based on the member's contract terms, applicable benefit limitations, and any exclusions in the member's plan.
Use of high-frequency chest wall compression systems and intrapulmonary percussive ventilation (IPV) devices for indications other than those specifically described in this policy (and many applications in COPD) is considered investigational due to insufficient evidence of net health benefit. Oscillatory devices may be appropriate as alternatives for individuals who cannot perform manual chest physical therapy, but off-label or broader use beyond the specified diagnoses and criteria is not supported by the evidence summarized in this policy.
This portion of the document does not list an explicit, itemized set of conditions labeled "not medically necessary." Providers should interpret investigational or unsupported uses and exclusions described elsewhere in the policy, and confirm coverage decisions against the member's contract and benefit limits.
Coding and Diagnosis References
| BYI | FDA product code (oscillatory devices) |
| BYT | FDA product code (oscillatory devices) |
| E84.0 | Cystic fibrosis with pulmonary manifestations |
| E84.11 | Meconium ileus in cystic fibrosis |
| E84.19 | Cystic fibrosis with other intestinal manifestations |
| E84.8 | Cystic fibrosis with other manifestations |
| E84.9 | Cystic fibrosis, unspecified |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J43.0 | Unilateral pulmonary emphysema [MacLeod's syndrome] |
| J43.1 | Panlobular emphysema |
Prior Authorization, Documentation, and Billing Guidance
Prior Authorization / Eligibility Verification Recommended
Prior authorization is recommended. Verify member benefits, eligibility on the date of service, and medical necessity prior to providing airway clearance devices. Contact Capital Blue Cross Provider Services or Member Services for questions about coverage determinations.
- Verify member benefits and eligibility prior to service
- Confirm medical necessity and appropriate coding before submitting claims
Device Coverage Contingent on Failure/Intolerance/Unavailability of Standard Chest Physical Therapy
Coverage is contingent on demonstrated need for airway clearance and on failure, intolerance, or unavailability of standard chest physical therapy. The device is medically necessary only when there is documented clinical evidence of poor or failed outcomes using conventional chest physical therapy (e.g., frequent severe exacerbations with inability to clear mucus despite standard therapy) or when standard therapy cannot be tolerated or is unavailable.
- Device coverage requires prior trial and failure/intolerance of standard chest physical therapy or documented unavailability
- Oscillatory PEP devices may be considered when standard therapy fails or is not tolerated
Documentation During 30-Day Trial
Document daily use during the initial trial and clinical response. Documentation must demonstrate the device was used daily or as prescribed and show increased expectoration of mucus. At the end of a 30-day trial, include review of compliance and evidence of stable or improved respiratory status to justify continued rental or purchase.
- Record daily prescribed use and adherence during the 30-day trial
- Document increased expectoration and clinical improvement or stabilization
- If ongoing therapy is medically necessary, rental may continue up to 10 months, after which purchase may be considered
Claims Coding Recommendations
Claims should include appropriate HCPCS procedure codes and supporting diagnosis codes. Include procedure codes for the device supplied or rented and relevant ICD-10 diagnosis codes that justify medical necessity.
Denial Risk Factors
Lack of demonstrated need, absence of a prior trial of standard chest physical therapy (or missing documentation of intolerance/unavailability), or incomplete trial documentation may result in denial of coverage. Ensure all required documentation and prior authorization steps are completed to reduce denial risk.
- Failure to document need for airway clearance can result in noncoverage
- Missing evidence of trial, compliance, or clinical response increases denial risk
Coverage/Payment Conditions
This policy and payment are subject to the member's benefit program, eligibility on the date of service, and determination of medical necessity. Treating providers remain responsible for medical advice and treatment decisions.
- Coverage/payment subject to member benefit program and eligibility
- Medical necessity determination required for payment
Background and Scope
Oscillatory airway clearance devices — including oscillating PEP devices (for example, Flutter and Acapella) and high-frequency chest wall oscillation systems — are alternatives to manual chest percussion and postural drainage to mobilize mucus. Some oscillatory devices require active patient participation, while others (such as passive vest-type systems) provide external chest oscillation. These devices may benefit patients who cannot perform or do not have caregivers to perform manual chest physical therapy, but evidence across indications (cystic fibrosis, bronchiectasis, COPD) is limited and heterogeneous, and additional robust trials are needed to establish net health benefit.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.